Neuralink

Creating a generalized brain interface to restore autonomy to those with unmet medical needs today and unlock human potential tomorrow

Health 📍 Fremont, California Founded 2016

Current Valuation

$15B

as of 2025-Q2

DECACORN

Neuralink develops implantable brain-computer interfaces that translate neural signals into digital actions, enabling people with paralysis to control computers and robotic devices with their thoughts. The company serves patients with severe neurological conditions including paralysis, blindness, and speech impairment. Neuralink represents a critical breakthrough in neurotechnology with FDA breakthrough designations for multiple devices and growing human clinical trials.

Company Profile

CEO

Jared Birchall

Founded

2016

Fremont, California

Employees

~600

Total Raised

$1.3B

Growth

pre-revenue, scaling to $1B by 2031

Last Round

Series E — $650M (Jun 2025)

IPO Status

none

Founders & Key People

Elon MuskMax HodakBenjamin RapoportDongjin SeoPaul MerollaPhilip SabesTimothy J. GardnerTim HansonVanessa Tolosa

Investors

ARK Invest · Founders Fund · Sequoia Capital · Thrive Capital · DFJ Growth · G42 · Human Capital · Lightspeed · QIA · Valor Equity Partners · Vy Capital

Products

Telepathy brain-computer interface
Blindsight visual prosthesis
N1 Link implantable brain chip
R1 Robot surgical system
Neuralink Application software
PRIME Study clinical trial program

Competitors

Synchron · Paradromics · Precision Neuroscience · Blackrock Neurotech · Science Corporation

Brain-Computer InterfaceMedical DeviceNeurotechnologyDeep TechDecacorn